1.
Epidemiology and etiology of Parkinson's disease: a review of the evidence
by Wirdefeldt, Karin
European journal of epidemiology, 2011, Vol.26 (Suppl 1), p.S1-S58
2.
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
by Tkatch, Tatiana
Nature, 2007, Vol.447 (7148), p.1081-1086
3.
Ageing, neurodegeneration and Parkinson’s disease
by Hindle, John V
Age and ageing, 2010, Vol.39 (2), p.156-161
4.
Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism
by Rosin, Boris
Neuron (Cambridge, Mass.), 2011, Vol.72 (2), p.370-384
5.
Genetic Analysis of Pathways to Parkinson Disease
by Hardy, John
Neuron (Cambridge, Mass.), 2010, Vol.68 (2), p.201-206
6.
Missing pieces in the Parkinson's disease puzzle
by Obeso, Jose A
Nature medicine, 2010, Vol.16 (6), p.653-661
7.
Clinicoradiological comparison between vascular parkinsonism and Parkinson’s disease
by Vale, Thiago Cardoso
Journal of neurology, neurosurgery and psychiatry, 2015, Vol.86 (5), p.547-553
8.
Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes
by Wang, Wenzhang
Nature medicine, 2016, Vol.22 (1), p.54-63
9.
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
by Williams-Gray, Caroline H
Journal of neurology, neurosurgery and psychiatry, 2013, Vol.84 (11), p.1258-1264
10.
Test-Retest Reliability and Minimal Detectable Change on Balance and Ambulation Tests, the 36-Item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in Peopl...
by Steffen, Teresa
Physical therapy, 2008, Vol.88 (6), p.733-746
11.
Cueing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial
by Nieuwboer, A
Journal of neurology, neurosurgery and psychiatry, 2007, Vol.78 (2), p.134-140
12.
Gender differences in Parkinson’s disease
by Haaxma, Charlotte A
Journal of neurology, neurosurgery and psychiatry, 2007, Vol.78 (8), p.819-824
13.
RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
by MacLeod, David A
Neuron (Cambridge, Mass.), 2013, Vol.77 (3), p.425-439
14.
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
by Vriend, Chris
Journal of neurology, neurosurgery and psychiatry, 2014, Vol.85 (2), p.159-64
15.
Cognitive Contributions to Freezing of Gait in Parkinson Disease: Implications for Physical Rehabilitation
by Peterson, Daniel S
Physical therapy, 2016, Vol.96 (5), p.659-670
16.
ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson’s Disease
by Valadas, Jorge S
Neuron (Cambridge, Mass.), 2018, Vol.98 (6), p.1155-1169.e6
17.
Mild cognitive impairment in Parkinson's disease
by Yarnall, Alison Jane
Age and ageing, 2013, Vol.42 (5), p.567-576
18.
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
by Schapira, Anthony H V, Prof
The Lancet (British edition), 2014, Vol.384 (9942), p.545-555
19.
Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study
by Benito-León, J
Journal of neurology, neurosurgery and psychiatry, 2009, Vol.80 (4), p.423-97
20.
Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model
by Steinbeck, Julius A
Nature biotechnology, 2015, Vol.33 (2), p.204-209
